fbpx
Friday, December 9, 2022

KKM signs MoU with Straumann Group to provide dental implant treatment benefits to the B40 

NewsKKM signs MoU with Straumann Group to provide dental implant treatment benefits...

The Health Ministry (KKM) has recently signed a memorandum of understanding (MoU) with Straumann Group Sdn Bhd to provide dental implant treatment benefits to the B40 group.

The Straumann Group is a global leader in implantology and esthetic dentistry and under the MoU, it will provide 3,000 packages of complete dental implant treatment that are worth over RM10 million to those in need.

This was announced by Health Minister Khairy Jamaluddin in a statement on Thursday (19 May) and he said that the details of the packages will be soon revealed.

“Oral health is well-being that encompasses a variety of important functions including breathing, nutrition, speech, smiling and social life.”

“Having optimal oral health will add value to the comfort and confidence of the individual to achieve the best capacity as well as engagement with the surrounding community,” he said.

He then mentioned that according to the National Oral Health Survey for Adults in 2010, one in four adults in Malaysia had a prosthesis due to tooth loss.

He added that 45.9% of those still with teeth need a prosthesis to replace a missing tooth while one in three toothless adults also need a prosthesis.

“Therefore, many people still need treatment for the replacement of lost teeth to restore the main functions of the mouth,” he said.

Khairy said dental implants are replacement treatments made from biochemical materials such as titanium and help to restore the main functions of the mouth.

In addition, there won’t be any side effects on the patient’s body and bones while it can stick directly to the titanium surface.

These implants will not interfere with nearby teeth and are easier to clean as compared to other fixed prostheses.

However, Khairy said that only cases that meet the criteria can be given this dental implant treatment.

The treatment would need to be monitored closely because studies showed that 19 to 65% of patients who receive dental implant treatment get mucositis, while 1 to 47% get inflammatory diseases (peri-implantitis) if they fail to be monitored regularly.

“In order to ensure the success of the dental implant programme so that it would not lead to any complication, close and continued monitoring by the MOH and commitment from the patients to attend follow-up checkups, are very important.” Khairy added.

Trending now

- Advertisement -

Subscribe to our newsletter!

Recommended for you